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The susceptibilities of gram-positive organisms towards
beta-lactam were low. Susceptibilities of cloxacillin,
ampicillin and penicillin were 60% (9/15), 26.3% (5/19)
and 34.8% (8/23) respectively. Among all gram-negative
organisms, only 13 (65%) of them were sensitive to
ceftazidime during the whole study period. Such
susceptibilities were observed to be decreasing from 75%
in 2001-2004 period to 58.3% in 2005-2008 period. This is
closely related to the emergence of extended-spectrum beta-
lactamase (ESBL). On the other hand, amikacin enjoyed a
reasonably high susceptibilities rate of 82.1% (23/28).
Underlying disease, duration and severity of neutropenia,
use of antibiotic prophylaxis or steroid, infective focus are
not associated with the type of organism.
Conclusion: In contrast to worldwide trend, gram-
negative bacteremia is increasingly more common.
Ceftazidime monotherapy may be insufficient as the
empirical antibiotic due to rising resistance among gram-
negative organisms. Moreover, most gram-positive
organisms are resistant to beta-lactam. Therefore, the
combination of beta-lactam/beta-lactamase inhibitor and an
aminoglycoside, is a reasonable choice that cover most of
the pathogens causing bacteremia in our paediatric oncology
centre.
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Infection is among the leading causes of death for
thalassemia major patients. The known predisposing factors
of infection include prior splenectomy, iron overload and
use of iron chelator such as desferal (desferrioxamine).
While encapsulated organisms frequently found in
splenectomized patients were readily controlled by
prophylactic vaccination and vigilant antibiotic treatment,
ferrophilic organisms such as Yersinia and Klebsiella
remains common among Thalassemic patients. The
inductive iron overloaded environment favours the growth
of these organisms but their growth is also affected by the
environment temperature. For example, Yersinia infection
is more prevalent in temperate regions and Klebsiella
infection is commonly found in subtropical areas.
Furthermore, the use of iron chelator in the form of desferal
further aggravates the risk of Yersinia infection. It is because
the iron membrane transport protein siderophore found in
desferal can be adopted by the bacteria for iron acquisition.
However, oral chelators such as deferiprone do not enhance
growth of Yersinia in vitro or in vivo. In order to find out
whether such observation can be extended to Klebsiella and
Aeromona infection, in vitro culture assay using Klebsiella
pneumoniae and Aeromonas hydrophila obtained directly
from our transfusion dependent thalassaemic patients were
performed. The growth rates of the bacteria under iron rich,
iron poor with or without different chelators were assessed.
The growth rates were analyzed by both: (1) optic density
of bacterial broth; and (2) colony count by bacterial agar
plate. We found that the growth of Klebsiella was marginally
enhanced by desferal in vitro when compared to Yersinia.
Such unfavourable effect was not found in either deferiprone
or deferasirox in vitro. On the other hand, the growth of
Aeromonas was not affected by the presence of any of the 3
chelators. Therefore, we suggested that factors other than
desferal may account for the increase prevalence of
Klebsiella and Aeromonas infection among Asian
thalassemic patients. It also suggests that oral chelators are
safe for thalassemic patients during febrile illness. Unlike
desferal, withholding iron chelator during infectious period
may not be mandatory. But care has to be exercised
especially for patients on deferiprone, since neutropenia has
to be ruled out during febrile illness.
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Introduction: Ventilator associated pneumonia (VAP) is
one of the most common nosocomial infection in Neonatal
Intensive Care Unit (NICU) in Hong Kong. It is associated
with increased mortality and length of stay. In the past,
ventilator circuit were thought to be one of the main factors
in causing VAP and ventilator circuits were changed
frequently. Changing of ventilator circuit occupies a large
volume of nursing time. Now it is well known that VAP is
mainly associated with aspiration of the contaminated
oropharyngeal secretions or esophargeal reflux from the
stomach. Researches in adult population favoured less
frequent changes too.
Intervention: The use of ventilator circuit were extended
from 7 days to 14 days for both invasive (intubated) and
non-invasive (nasal Prong) ventilation from February 2007.
Aim: The aim of this study is to test whether extending
